Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1945]
News [3579]
Articles [92]
Editorials [5]
Conferences [157]
elearning [19]
ASH 2024: Anitocabtagene autoleucel demonstrates 97% ORR and 62% CR/sCR in relapsed or refractory multiple myeloma
ASH 2024: Anitocabtagene autoleucel demonstrates 97% ORR and 62% CR/sCR in relapsed or refractory multiple myeloma
ASH 2024: Belantamab mafodotin shows significant OS benefit, reducing risk of death by 42% in multiple myeloma at or after first relapse
ASH 2024: Belantamab mafodotin shows significant OS benefit, reducing risk of death by 42% in multiple myeloma at...
ASH 2024: Could venetoclax improve outcomes of CAR T for patients with resistant B-cell lymphomas?
ASH 2024: Could venetoclax improve outcomes of CAR T for patients with resistant B-cell lymphomas?
Therapeutic potential of a novel mixture of mRNA in nanoparticles overcomes tumour progression
Therapeutic potential of a novel mixture of mRNA in nanoparticles overcomes tumour progression
ASH 2024: Preclinical study shows targeted drug strengthens the power of CAR T-cell therapy in two paediatric leukaemias
ASH 2024: Preclinical study shows targeted drug strengthens the power of CAR T-cell therapy in two paediatric...
ASH 2024: Study reveals how venetoclax boosts immune response to CAR T for chronic lymphocytic leukaemia
ASH 2024: Study reveals how venetoclax boosts immune response to CAR T for chronic lymphocytic leukaemia
ASH 2024: Ketogenic diet boosts CAR T-Cell function for better tumour control
ASH 2024: Ketogenic diet boosts CAR T-Cell function for better tumour control
Opioids interfere with cancer immunotherapy but these drugs could help
Opioids interfere with cancer immunotherapy but these drugs could help
Innovative immunotherapy shows promise in early clinical trial for breast cancer
Innovative immunotherapy shows promise in early clinical trial for breast cancer
Studies look at making immunotherapy both faster and stronger
Studies look at making immunotherapy both faster and stronger

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation